Co-Diagnostics, Inc. Company Description: Founded in 2013 on the principle of making affordable PCR tests available worldwide, Co-Dx™ is a molecular diagnostics provider with unique, patented technology which enables the design of high performing, cost-effective PCR for infectious diseases, at-home/point-of-care, SNP detection, vector surveillance, liquid biopsy and more. Visit us at the 4th Annual Infectious Diseases and Molecular Diagnostic Conference to see how were making our revolutionary Co-Primer™ technology available around the world.
LumiraDx is transforming healthcare with fast, accurate and comprehensive diagnostics at the point of need. With the LumiraDx Platform, and Fast Lab Solutions unit, LumiraDx supports diagnostic needs across settings; from the lab, to hospitals, the physician’s office, the workplace, and schools. Founded in 2014, LumiraDx is based in the UK with R&D and manufacturing sites across the US and Europe.
AusDiagnostics is a manufacturer and supplier of highly multiplexed, automated molecular assays for the detection of pathogens and antibiotic resistance markers (respiratory including Sars-Cov 2, enteric, STIs, HPV etc) from a wide range of clinical samples.
Key advantages of our approach are low cost, ease of use and a unique MT-PCR process that preserves the quantitative relationship between pathogens in the original sample. Our system is coupled with easy to use software and we can supply equipment and IVD kits for laboratories of all sizes.
As an established IVD company, Randox Biosciences offers tailored diagnostic solutions to support faster, more effective and safe development of new drugs.
Randox have a wide range of in house capabilities, ranging from the development of novel Biomarkers; manufacture of antibodies (mAb, sdAb); production of single and multiplex IVD grade tests; quality control; provision of clinical laboratory services; regulatory expertise and worldwide distribution.
Choose Randox Biosciences as your companion diagnostic partner to ensure the safety and quality of your drug development process.
Pro-Lab Diagnostics specialise in the development, manufacture, and distribution of In Vitro Diagnostics kits and reagents as well as automated specialist equipment for the Biomedical Science Industry. We are pleased to support the congress and share details of our products including one of the most comprehensive ranges of RT-PCR kits currently available, Viasure, V-Lab and V-Flex. We are also looking to further discuss our work in the field of NGS.
Mico Bio Med established since 2000, have been committed to improving and saving lives by offering innovative, market world leading IVD technologies. We have been overcoming countless limitations of traditional IVD devices by developing a ground breaking “Lab-on-a-Chip” (Lab Chip) based technology which enable us to deliver POCT (Point-of-care Testing) quickly and accurately.
MiCo BioMed has been leading the global POCT (Point-of-care Testing) market by integrating molecular, biochemical, and immunological diagnostic technologies over the last few decades.
By expanding applicability and interoperability of different diagnostic technologies, MiCo BioMed strives to lead the global IVD Market. Our in-house research institute has highly competent and dedicated research scientists with deep expertise, taking innovative future approaches into vitro diagnostics.
Our Immunodiagnostic Kits(β-hCG, Cardiac Marker, Yellow Fever, COVID-19, Hepatitis, Monkey Box), Rapid Diagnostic Test Kit, ELISA Kit, Clinical, Food, Animal Diagnostics, Device manufacture, well over 300 Assays Reagents developed by our team to date and a wide variety of current and new kits for use in and out of Laboratory settings.
altona Diagnostics supply high quality molecular test systems for the detection and quantification of infectious disease pathogens. The AltoStar® product range enables an advanced ‘sample to result’ CE IVDR workflow for RT-PCR testing. AltoStar® assays include HIV, HCV, HBV, HEV, CMV, EBV, Adenovirus, BKV, JCV, HSV, VZV, Parvovirus, HHV6, a-Herpes, Influenza, SARS Cov-2. Furthermore, the new complementary FlexStar® range brings a novel approach to syndromic testing allowing the customer to define their own multiplex testing panel.